Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Evrydiki Michalis"'
Autor:
Efstathios Kastritis, Marie-Christine Kyrtsonis, Pierre Morel, Maria Gavriatopoulou, Evdoxia Hatjiharissi, Argirios S. Symeonidis, Amalia Vassou, Panagiotis Repousis, Sossana Delimpasi, Anastasia Sioni, Evrydiki Michalis, Michail Michael, Elina Vervessou, Michael Voulgarelis, Costantinos Tsatalas, Evangelos Terpos, Meletios A. Dimopoulos
Publikováno v:
Haematologica, Vol 100, Iss 11 (2015)
Externí odkaz:
https://doaj.org/article/55bc2969454f4c1da6f7bb2084ba77f2
Autor:
Anastasia Sioni, Elina Vervessou, Efstathios Kastritis, Michail Michael, Maria Gavriatopoulou, Meletios A. Dimopoulos, Panagiotis Repousis, Constantinos Tsatalas, Pierre Morel, Amalia Vassou, Argirios S. Symeonidis, Evdoxia Hatjiharissi, Marie-Christine Kyrtsonis, Evrydiki Michalis, Evangelos Terpos, Sossana Delimpasi, Michael Voulgarelis
Publikováno v:
Haematologica. 100(11)
WM is a disease of the elderly with a protracted course in many patients and a median survival of 7 to 10 years,[1][1] however, in many patients, other factors rather than WM or its treatment may be the cause of death.[2][2] Non-WM-related mortality
Autor:
Nikolaos Anagnostopoulos, George Gortzolidis, Alexandra Tsakri, Antonios Angelidis, Theodore Marinakis, Ioanna Savvidou, Ioanna Michail, Athanasios Zomas, Ioannis Tsourveloudis, George Paterakis, Helen Goumakou, Vasilios Xanthopoulos, Maria Georgiakaki, Elpiniki Griva, Myrsini Pergaminou, Evrydiki Michalis, Athanasios Galanopoulos
Publikováno v:
Blood. 110:4372-4372
The value and exact type of intensive chemotherapy of unselected elderly AML patients in terms of overall survival (OS) and quality of life remains controversial. Despite recent improvements in supportive measures during cytotoxic therapy, elderly AM